In trading on Wednesday, shares of Immunocore Holdings PLC (Symbol: IMCR) crossed below their 200 day moving average of $59.48, changing hands as low as $59.32 per share. Immunocore Holdings PLC ...

ROCKVILLE, Md., US, 24 April 2024) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Goldman Sachs analyst Rajan Sharma has maintained their bullish stance on IMCR stock, giving a Buy rating yesterday. Rajan Sharma has given his Buy rating due to a combination of factors that ...

In trading on Friday, shares of Immunocore Holdings PLC (Symbol: IMCR) entered into oversold territory, hitting an RSI reading of 29.5, after changing hands as low as $53.56 per share. By ...

Oppenheimer analyst Jeff Jones maintained a Buy rating on Immunocore Holdings (IMCR – Research Report) today and set a price target of $87.00. The company’s shares closed last Friday at $48.98.